Shivani Subudhi - Wuhan General Head Marketing
| WUHNDelisted Stock | USD 0.0004 0.00 0.00% |
Insider
Shivani Subudhi is Head Marketing of Wuhan General Gr
| Phone | 514-928-7368 |
| Web | https://wuhn.org |
Wuhan General Management Efficiency
Wuhan General's management efficiency ratios could be used to measure how well Wuhan General manages its routine affairs as well as how well it operates its assets and liabilities.Wuhan General Gr currently holds 118.8 M in liabilities with Debt to Equity (D/E) ratio of 1.11, which is about average as compared to similar companies. Wuhan General Gr has a current ratio of 1.08, suggesting that it may not have the ability to pay its financial obligations when due. Debt can assist Wuhan General until it has trouble settling it off, either with new capital or with free cash flow. So, Wuhan General's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Wuhan General Gr sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Wuhan to invest in growth at high rates of return. When we think about Wuhan General's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Frantz Devedec | Avicanna | N/A | |
| Matthew Darin | Curaleaf Holdings | N/A | |
| Dennis Curran | Acreage Holdings | N/A | |
| Jason Green | Canopy Growth Corp | N/A | |
| Carlos Cortez | Cronos Group | 51 | |
| Patricia Rosi | Acreage Holdings | N/A | |
| Thomas Shipley | Canopy Growth Corp | 30 | |
| Theresa Yanofsky | Canopy Growth Corp | 63 | |
| Andrew Stordeur | SNDL Inc | 44 | |
| Steve West | Acreage Holdings | N/A | |
| David Abitbol | Cannara Biotech | N/A | |
| Jakob Feinstein | Curaleaf Holdings | N/A | |
| Jonathan Tosto | Canopy Growth Corp | N/A | |
| Jimes Sabia | Canopy Growth Corp | 58 | |
| FCPA FCA | Canopy Growth Corp | 63 | |
| Robbie Madan | SNDL Inc | 45 | |
| Caitlin Johnston | Avicanna | N/A | |
| France Landry | Cannara Biotech | N/A | |
| Kevin Murphy | Acreage Holdings | 61 | |
| Julious Grant | Canopy Growth Corp | 56 | |
| Carlos Muete | Avicanna | N/A | |
Management Performance
| Return On Equity | -0.0878 | ||||
| Return On Asset | -0.005 |
Wuhan General Gr Leadership Team
Elected by the shareholders, the Wuhan General's board of directors comprises two types of representatives: Wuhan General inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Wuhan. The board's role is to monitor Wuhan General's management team and ensure that shareholders' interests are well served. Wuhan General's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Wuhan General's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Anna Morera, Chief Medical Officer | ||
| Carol Pan, Principal Officer | ||
| Luka MSc, Director Communication | ||
| Huang Zhaoqi, Vice Director | ||
| Johann Mcloughlin, Head Design | ||
| Shivani Subudhi, Head Marketing | ||
| Willem Jonker, Chief Officer | ||
| Samuel Williams, Head Foods | ||
| Jeffrey Robinson, Chairman Founder | ||
| AAg MSc, Chief Officer |
Wuhan Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Wuhan General a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0878 | ||||
| Return On Asset | -0.005 | ||||
| Profit Margin | (0.13) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 3.05 M | ||||
| Shares Outstanding | 33.93 M | ||||
| Number Of Shares Shorted | 12.62 K | ||||
| Price To Earning | (0.06) X | ||||
| Price To Book | 0.04 X | ||||
| Price To Sales | 0.05 X |
Pair Trading with Wuhan General
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Wuhan General position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wuhan General will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Wuhan General could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Wuhan General when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Wuhan General - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Wuhan General Gr to buy it.
The correlation of Wuhan General is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Wuhan General moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Wuhan General Gr moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Wuhan General can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in Wuhan Pink Sheet
If you are still planning to invest in Wuhan General Gr check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Wuhan General's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |